Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.
Message: Re: B-Lunist - Letter to Shareholders So the J3 are not paying any royalties
8
May 12, 2008 10:03AM
4
May 12, 2008 10:08AM
May 12, 2008 10:13AM
May 12, 2008 10:16AM
2
May 12, 2008 10:19AM
1
May 12, 2008 10:26AM
5
May 12, 2008 10:42AM
11
May 12, 2008 10:44AM
May 12, 2008 10:52AM
6
May 12, 2008 11:04AM
4
May 12, 2008 11:05AM
1
May 12, 2008 11:14AM
8
May 12, 2008 11:38AM
1
May 12, 2008 12:00PM
4
May 12, 2008 12:25PM
May 12, 2008 12:43PM
3
May 12, 2008 12:49PM
1
May 12, 2008 01:02PM
7
May 12, 2008 01:38PM
IMO Judge Ward holds the MOU that will require the J's to pay more money for the license when/if the USPTO revalidates the patents. Until then the J's are granted a license to continue selling goods that utilize the MMP patents. If the patents are not re-validated then the J's and all remaining companies will not need to pay for a license period. Come on USPTO!
All the best,
Steve
2 Recommendations
Loading...
Loading...
May 12, 2008 02:45PM
4
May 13, 2008 06:17AM
2
May 13, 2008 05:02PM
New Message
Please
login
to post a reply